Contact Medicilon

Contact Us

Name(Required)
Address(Required)

Search Medicilon

Preclinical CRO

EFMC-ISMC 2026

Preclinical CRO

Medicilon Delivers One Stop Preclinical Support as Yizhong Pharma Secures NMPA Clinical Approval for YXC‑001 Tri‑functional Antibody Fusion Protein and YXC‑002 4th‑Generation EGFR Kinase Inhibitor

Preclinical CRO

4th SMC and AimedBio ADC Conference

Contact Medicilon

Name(Required)
Address(Required)